Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc.Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed private placement financing of up to
Avalo Therapuetics (AVTX) Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nkarta (NASDAQ:NKTX – Free Report) had its target price decreased by Mizuho from $31.00 to $25.00 in a report published on Friday morning, Benzinga reports. Mizuho currently has a buy rating on the stock. NKTX has been the subject of a number of other reports. HC Wainwright decreased their price target on Nkarta from $22.00 […]
Nkarta Announces Pricing of $240 Million Underwritten Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reaffirmed their buy rating on shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a $30.00 target price on the stock. Other equities analysts have also issued research reports about the stock. Oppenheimer increased their target price […]